Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - glucose, quantity: 500 mg/ml - injection, intravenous infusion - excipient ingredients: hydrochloric acid; water for injections; sodium bicarbonate - glucose 50% intravenous infusion is strongly hypertonic and may be used to reduce increased cerebrospinal pressure and/or oedema due to delirium tremens or acute alcoholic intoxication. it may also be used to treat severe hypoglycaemia due to an excess of insulin and to provide concentrated calories in total parenteral nutrition regimes.

Bangladesh - English - DGDA (Directorate General of Drug Administration)

orion infusion ltd. - sodium chloride - iv infusion - 3 gm/100 ml

Bangladesh - English - DGDA (Directorate General of Drug Administration)

orion infusion ltd. - paracetamol - iv infusion - 1 gm/100 ml

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - dexmedetomidine hydrochloride, quantity: 4.72 microgram/ml (equivalent: dexmedetomidine, qty 4 microgram/ml) - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections - intensive care unit (icu) sedation: for sedation of initially intubated adult patients during treatment in an intensive care setting. the use of precedex ready to use by continuous infusion in these patients should not exceed 24 hours.,procedural sedation: for sedation of non-intubated adult patients prior to and/or during surgical and other procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - dexmedetomidine hydrochloride, quantity: 4.72 microgram/ml (equivalent: dexmedetomidine, qty 4 microgram/ml) - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections - intensive care unit (icu) sedation: for sedation of initially intubated adult patients during treatment in an intensive care setting. the use of precedex ready to use by continuous infusion in these patients should not exceed 24 hours.,procedural sedation: for sedation of non-intubated adult patients prior to and/or during surgical and other procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - dexmedetomidine hydrochloride, quantity: 4.72 microgram/ml (equivalent: dexmedetomidine, qty 4 microgram/ml) - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections - intensive care unit (icu) sedation: for sedation of initially intubated adult patients during treatment in an intensive care setting. the use of precedex ready to use by continuous infusion in these patients should not exceed 24 hours.,procedural sedation: for sedation of non-intubated adult patients prior to and/or during surgical and other procedures.

Canada - English - Health Canada

fresenius kabi canada ltd - chorionic gonadotropin - powder for solution - 10000unit - chorionic gonadotropin 10000unit - gonadotropins and antigonadotropins

Singapore - English - HSA (Health Sciences Authority)

orion pharma (sg) pte. ltd. - dexmedetomidine hydrochloride eqv dexmedetomidine - infusion, solution concentrate - dexmedetomidine hydrochloride eqv dexmedetomidine 100 mcg/ml

Bangladesh - English - DGDA (Directorate General of Drug Administration)

orion infusion ltd. - amino acids (essential) - iv infusion - 5 %

Bangladesh - English - DGDA (Directorate General of Drug Administration)

orion infusion ltd. - amino acids (essential) + glucose & electrolytes - iv infusion - 7 % + 10 %